Labcompliance On-line Audio Seminar

This seminar has been recorded and is available on CD and for instant download. All reference material as listed below and more is available on a special seminar website. The website is regularly updated with most recent information. In case there are questions related to the topic, they can be submitted through a web form and will be answered by the speaker. For ordering info click here
To share this seminar info with your colleagues, click here.

On-line Audio Seminar 283

Quality by Design (QbD) for  Development and Validation of Analytical Methods

Learn how  to design robustness for easy transfer and to avoid OOS situations

Recorded, available with all reference material at any time

Using the QbD approach for development and validation will result in more robust analytical methods. Advantages are easier method method transfer, longer revalidation cycles and fewer or no methods specific Out-of-Specification situations when used in routine.  In addition FDA and international agencies promote the QbD approach because it is expected that such performance based routine methods can be changed within the analytical target profile (ATP) without regulatory  resubmission and approval. Because there is no or little experience with the QbD approach for analytical methods the industry has many questions.

Key Questions related to Quality by Design and Method Validation

• What does it mean: Quality by design?
• What is the regulatory background: ICH, FDA, Europe, Asia, PIC/S?
• Where and how is the industry already using the QbD approach?
• Why should we change the way we develop and validate methods?
• What is the main difference to the current validation approach based on ICH Q2?
• What are the advantages of QbD for method validation?
• How to apply risk assessment for method validation?
• What are the drawbacks, if there are any?
• What are the steps of the QbD approach?
• How to define the 'design space'?

How does the audio seminar help:

Answers will be presented by Dr. Ludwig Huber in a new interactive audio seminar. During the seminar, the speaker will present strategies and an overview and give practical recommendations. After the seminar, an extensive list of reference material like SOPs, test scripts, templates and examples will help immediate and cost effective implementation.

During the interactive presentation you learn about:

• General principles and key benefits of QbD
• Regulatory background and trends: FDA, ICH Q8/9/10
• Reasons for changing the way we validate methods
• Current applications of QbD in the pharmaceutical industry
• The Application of QbD for analytical methods
• Comparison of the QbD process with ICH Q2 and USP <1225>
• Benefits for method transfer and routine use
• Using the lifecycle approach for method design, development and validation
• Using the risk assessment prioritization matrix to select the test parameters
• The timeline for method design, validation and verification
• Using the method in the routine: re-verification and change control
• Documentation requirements
• Defining the Analytical Target Profile (ATP) and design space
• Case studies

 And for easy and instant implementation:
download 10+ documents from special seminar website

• Slides as PowerPoint Presentation, Script, Questions and Answers
• Master plan - Template and examples: Development and Validation of Analytical Methods through QbD
• SOPs
  - Development and Validation of Analytical Methods through Quality by Design
  - Transfer of Analytical Methods
• Case Study: Analytical Method Transfer Protocol
• Checklist
  - Transfer of Analytical Methods and Procedures
• Templates
  - Analytical Target Profile for selected HPLC methods
  - Design space for selected HPLC methods
  - Risk Prioritization Matrix for Quality by Design based Method Validation
• Reference Articles
  - QbD for Better Method Validation and Transfer (link)
  - Quality by Design Systematic Chromatographic Method Development
    (Poster, link)
  - A Lifecycle Concept for Pharmaceutical Analysis (link)
• FDA Presentation:
  - Implementing Quality by Design
  - FDA Update on Implementation of Quality by Design (QbD)
  
• FDA Warning-letters related to method validation
• ICH Guidelines for the Industry
  - Validation of Analytical Procedures: Text and methodology
  - ICH Q8, Q9, Q10

Who should attend?

• Laboratory managers and staff
• Analysts
• QA managers and personnel
• Regulatory affairs
• Training departments
• Documentation department
• Consultants

Date, time and duration

Recorded seminar, available at any time with all reference material

How to order

Pick one of the options in the table that fits your needs.

Recorded seminar - Web Download Multiple persons - single site Learn at your desk, meet in a seminar or conference room or share the audio file and reference material at your site. Order includes all reference material.	US$ 399.-
Recorded seminar - CD Get the CD in your mail Order includes all reference material.	US$ 399.-
Special offer for Labcompliance Usersclub Members Recorded Seminar- CD or Web download. Order includes all reference material. for Usersclub information and registration, click here	US$ 299.-

About audio seminars

 

Online audio seminars are presented over the phone. During the live presentation attendees can:

1. Study the printed slide material
2. Watch the slides on a computer
3. Watch the slides on a video screen in a seminar room
4. Ask questions through email and web form

 

About Dr. Ludwig Huber

Dr. Ludwig Huber is the author of the Labcompliance Newsletter. He has been conducting over 100 web and audio or video based seminars since ten years. He is worldwide director for FDA compliance at Agilent Technologies.

Dr. Ludwig Huber is a frequent presenter at IVT conferences and has been awarded as the 'Presenter of the Year' out of 170 speakers. This photo is from IVT's conference on Network Qualification with Ludwig Huber as plenary speaker.

Dr. Huber has published several books related to validation and compliance, for example: Validation of Computerized Analytical and Networked Systems. He was or still is a member of several committees, e.g., of the GAMP Special interest group (SIG) on Laboratory Computers, PDA Part 11 task force, IVT task force on network infrastructure qualification and the European Compliance Academy. He frequently visits FDA in Rockville, VA, and participates in panel discussions with FDA professionals. For more information, click here.